Skip to content
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
SV
EN
Press releases
Start
/
Newsroom
/
Press releases
Press releases
News
Investor letter
Media bank
Press releases
News
Investor letter
Media bank
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2021
2021-10-13 16:00
Status update on clinical trial for the treatment of relapsed prostate cancer patients
Regulatory
MAR
2021-07-12 13:00
Investor Letter July 2021
2021-05-18 15:45
SpectraCure AB publishes Quarterly Report 1, 2021
Regulatory
MAR
2021-04-15 14:00
The Nomination Committee's proposal for election of board members in SpectraCure AB
Regulatory
2021-03-15 08:45
Johan Folkunger appointed new CEO of SpectraCure AB
Regulatory
MAR
2021-03-05 08:30
Status update regarding clinical studies for the treatment of patients with recurrent prostate cancer
Regulatory
MAR
2020
2020-11-27 17:30
Positive discussions at SpectraCure's Investigator Meeting
Regulatory
2020-11-12 12:30
Interim Report Q3, 2020
Regulatory
MAR
2020-09-16 13:48
Looking for excellent, highly-skilled education and training in the vibrant field of Biophotonics? Apply now!
2020-08-25 08:30
Interim Report Q2, 2020
Regulatory
MAR
Previous
Next